ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31755-5mg |
|
1802637-39-3 |
BB-Cl-Amidine
|
0 | C26H26ClN5O | |
GC31755-1mg |
|
1802637-39-3 |
BB-Cl-Amidine
|
0 | C26H26ClN5O | |
GC31755-10mM(1mLinDMSO) |
|
1802637-39-3 |
BB-Cl-Amidine
|
0 | C26H26ClN5O | |
GC31754-100mg |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31754-50mg |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31754-25mg |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31754-10mg |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31754-5mg |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31754-1mg |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31754-10mM(1mLinDMSO) |
|
1873376-49-8 |
CXCR2-IN-1
|
0 | C19H20Cl2FN3O4S | |
GC31752-10mg |
|
781613-23-8 |
Tesevatinib (XL-647)
|
0 | C24H25Cl2FN4O2 | |
GC31752-5mg |
|
781613-23-8 |
Tesevatinib (XL-647)
|
0 | C24H25Cl2FN4O2 | |
GC31752-2mg |
|
781613-23-8 |
Tesevatinib (XL-647)
|
0 | C24H25Cl2FN4O2 | |
GC31752-10mM(1mLinDMSO) |
|
781613-23-8 |
Tesevatinib (XL-647)
|
0 | C24H25Cl2FN4O2 | |
GC31751-100mg |
|
1702816-75-8 |
PI3Kδ-IN-2
|
0 | C28H37FN6O5S | |
GC31751-50mg |
|
1702816-75-8 |
PI3Kδ-IN-2
|
0 | C28H37FN6O5S | |
GC31751-10mg |
|
1702816-75-8 |
PI3Kδ-IN-2
|
0 | C28H37FN6O5S | |
GC31751-5mg |
|
1702816-75-8 |
PI3Kδ-IN-2
|
0 | C28H37FN6O5S | |
GC31751-1mg |
|
1702816-75-8 |
PI3Kδ-IN-2
|
0 | C28H37FN6O5S | |
GC31751-10mM(1mLinDMSO) |
|
1702816-75-8 |
PI3Kδ-IN-2
|
0 | C28H37FN6O5S | |